GRAIL (NASDAQ:GRAL – Get Free Report) issued its earnings results on Thursday. The company reported ($2.44) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($3.33) by $0.89, Zacks reports. The business had revenue of $43.60 million during the quarter, compared to the consensus estimate of $43.33 million. GRAIL had a negative [...]
AngloGold: Gold price leverage ($2,600/oz avg) + Arthur Project (4.9Moz, $3.6B capex) validates scale, but 2026 costs up 11% ($1,335-1,455/oz) from royalties/FX, Lamar: Programmatic +19%, political tailwind $12-14M FY26, 4.8% yield, but margin pressure + EPS miss
AngloGold Q4 revenue $3.02B (+76% YoY) beat but EPS $1.90 missed $1.94—record FCF $2.9B FY25, $1.8B dividends (62% payout), net cash $879M, stock +5% to $113. Lamar Q4 revenue $596M (+2.8%) beat but EPS $1.50 missed $1.79—AFFO guide $8.50-8.70 (+4%), digital 34% mix, stock flat $133.
Five9 (NASDAQ:FIVN – Get Free Report) announced its earnings results on Thursday. The software maker reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44), Zacks reports. Five9 had a net margin of 2.77% and a return on equity of
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.06, FiscalAI reports. Pulse Biosciences Price Performance Shares of NASDAQ:PLSE traded down $0.38 during
